- TRIM5α is one of the most fascinating and biologically important members of the TRIM family of RING finger ubiquitin ligases. It is best known for its ability to recognise and block retroviral infections—most famously HIV‑1—through a unique combination of pattern recognition, capsid binding, ubiquitination, and autophagic degradation. TRIM5α acts as a powerful intracellular antiviral factor, forming part of the first line of defence against invading retroviruses.
- Structurally, TRIM5α contains the canonical tripartite motif: an N‑terminal RING finger domain, one or two B‑box domains, and a coiled‑coil region that mediates dimerisation and higher‑order assembly. What makes TRIM5α unique is its C‑terminal SPRY (B30.2) domain, which binds directly to the lattice of incoming retroviral capsids. This capsid‑binding specificity varies between species, explaining why human TRIM5α restricts some retroviruses but not HIV‑1, whereas rhesus macaque TRIM5α potently blocks HIV‑1 infection.
- Upon recognising a retroviral capsid, TRIM5α triggers a rapid antiviral response. Through its RING domain, TRIM5α catalyses the formation of K63‑linked ubiquitin chains, which act as signalling scaffolds rather than degradation tags. These chains activate downstream pathways such as NF‑κB, AP‑1, and IRF3, leading to the production of antiviral cytokines. At the same time, TRIM5α promotes autophagic degradation of the viral capsid, preventing reverse transcription and blocking infection at an early stage.
- TRIM5α’s ability to assemble into hexagonal lattices around the viral capsid is central to its function. These higher‑order assemblies increase avidity, allowing TRIM5α to “sense” the geometric pattern of the capsid surface. This pattern‑recognition mechanism resembles that of classical innate immune receptors, but with the added ability to directly destroy the pathogen.
- Beyond retroviral restriction, TRIM5α participates in innate immune signalling, protein quality control, and autophagy regulation. It interacts with factors such as TAK1 and TAB2, linking ubiquitination to inflammatory signalling. TRIM5α also helps maintain proteostasis by targeting misfolded proteins for autophagic clearance.
- TRIM5α has significant evolutionary and biomedical relevance. Its rapid evolution across primate species reflects an ongoing arms race between host and virus. Understanding TRIM5α’s capsid‑recognition mechanism has inspired antiviral strategies aimed at enhancing or mimicking its activity. Its ability to trigger selective autophagy also makes TRIM5α a model for studying intracellular pathogen clearance.
- In summary, TRIM5α is a specialised antiviral ubiquitin ligase that restricts retroviral infection through capsid recognition, ubiquitin signalling and autophagic degradation. Its tripartite motif provides structural stability and catalytic activity, while its SPRY domain confers unique pathogen‑sensing capabilities. TRIM5α remains a central focus in virology, immunology and evolutionary biology.
